US Patent Issued to Minovia Therapeutics, Tel Hashomer Medical Research Infrastructure and Services on April 21 for "Mitochondria-enriched genetically engineered cells and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,410, issued on April 21, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel) and Tel Hashomer Medical Research Infrastructure and Services Ltd. (Ramat Gan, Israel).

"Mitochondria-enriched genetically engineered cells and uses thereof" was invented by Natalie Yivgi-Ohana (Haifa, Israel), Noa Sher (Haifa, Israel), Moriya Blumkin (Tel Aviv, Israel) and Elad Jacoby (Ramat Gan, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based on the discovery that cells enriched with mitochondria are useful for treating diseases and disorders. Disclosed are pharmaceutical compositions of mitochondrially-enriched genetic...